Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E5555 in coronary artery disease
NCT00312052Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atopaxar in coronary artery disease (CAD), sponsored by Eisai Co., Ltd.. Started Sep 2007; status: completed.
02
Drugs
atopaxar
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00312052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312052.